BIOATLA, INC. 9,745,128 Shares of Common Stock Underwriting AgreementBioAtla, Inc. • November 7th, 2022 • Biological products, (no disgnostic substances) • New York
BioAtla, Inc., a Delaware corporation (the “Company”), proposes to issue and sell to J.P. Morgan Securities LLC, as underwriter (the “Underwriter”), an aggregate of 9,745,128 shares of common stock, par value $0.0001 per share, of the Company (the “Shares”). The shares of common stock of the Company to be outstanding after giving effect to the sale of the Shares are referred to herein as the “Stock”.
